ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 72 filers reported holding ITEOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $253,230 | -57.2% | 23,126 | -48.3% | 0.00% | – |
| Q2 2023 | $592,027 | -0.3% | 44,715 | +2.4% | 0.00% | – |
| Q1 2023 | $594,036 | -66.5% | 43,647 | -52.0% | 0.00% | -100.0% |
| Q4 2022 | $1,774,593 | +37.4% | 90,865 | +33.9% | 0.00% | 0.0% |
| Q3 2022 | $1,292,000 | -60.4% | 67,838 | -57.1% | 0.00% | 0.0% |
| Q2 2022 | $3,259,000 | -40.7% | 158,204 | -7.3% | 0.00% | -50.0% |
| Q1 2022 | $5,493,000 | +212.5% | 170,690 | +352.1% | 0.00% | +100.0% |
| Q4 2021 | $1,758,000 | +43850.0% | 37,756 | +27867.4% | 0.00% | – |
| Q3 2021 | $4,000 | -94.6% | 135 | -95.3% | 0.00% | – |
| Q2 2021 | $74,000 | -82.7% | 2,884 | -77.0% | 0.00% | – |
| Q1 2021 | $428,000 | +250.8% | 12,525 | +247.3% | 0.00% | – |
| Q4 2020 | $122,000 | – | 3,606 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |